Cross-Sector entity

Baxter

Company BAX
5

Of the tracked stories, 2 of 2 also mention Synchrony Financial, the most common co-covered peer. Coverage clusters in aerospace, which accounts for 1 of those 2, with the remainder spread across 1 other category. Each carries 3 original sources on average.

2 verified stories tracked

Last mentioned: Mar 19, 2026

Entity pulse

Recent coverage · Baxter

2 stories
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Baxter

Of the tracked stories, 2 of 2 also mention Synchrony Financial, the most common co-covered peer. Coverage clusters in aerospace, which accounts for 1 of those 2, with the remainder spread across 1 other category. Each carries 3 original sources on average. We currently track 2 Cross-Sector stories that mention Baxter, all published on March 19, 2026.

Stories tracked
2
Sources per story
3

Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Baxter. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Market Performance Review

    Analysts compare TXT performance favorably against financial and medical sector benchmarks.

  2. NTCSA Agreement

    Bell signs a helicopter purchase agreement with NTCSA to expand its international footprint.

  3. Institutional Buy-in

    Intech Investment Management LLC purchases additional shares of TXT, signaling confidence.

  4. Dividend Declaration

    Textron Inc. declares a quarterly dividend of $0.02 per share for shareholders.

Stories mentioning Baxter 2

Healthcare market trends Neutral 5

Market Trends: Baxter and Synchrony Performance Signals Healthcare Sector Shift

Recent stock performance comparisons for Baxter and Synchrony Financial highlight a diverging landscape between medical device manufacturing and healthcare consumer financing. While Baxter navigates portfolio optimization, Synchrony's CareCredit remains a critical indicator of consumer spending on elective health services.

3 sources